We are excited to announce that SyVento BioTech will be attending the World Vaccine Congress in Washington, D.C. from April 22-24, 2025! This premier event brings together industry leaders to discuss groundbreaking advancements in vaccine development across infectious diseases, cancer immunotherapy, veterinary vaccines, and more.
SyVento BioTech is committed to advancing vaccine technologies and biopharmaceutical solutions that have a significant impact on public health. We take pride in being at the forefront of developing innovative medicines, including mRNA-based drug products, by leveraging cutting-edge research and technology to address global health challenges.
